Filter announcements
Loading...
Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.With its registered office in Vadodra…
Alembic Limited updated contact details for its Managing Director, CFO, and Company Secretary. These contacts are authorized for determining materiality of information and making necessary disclosures to stock exchanges.
Alembic Ltd's RTA, MUFG Intime India, has introduced a new generic email ID, investor.helpdesk@in.mpms.mufg.com, for all investor inquiries. This change aims to streamline shareholder communication and provide a common contact point.
Alembic Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company is holding its 118th Annual General Meeting via video conference. The Annual Report for FY 2024-25 is available on the company’s website. Dividend payment is scheduled post-AGM. Shareholders are encouraged to...
Alembic Limited is urging shareholders to claim unpaid dividends from FY 2017-18 onward, warning that shares with unclaimed dividends for seven years may be transferred to the Investor Education and Protection Fund. Shareholders should update KYC and nomination details promptly. No financial impact has been indicated.
Alembic Limited has announced a board meeting to approve the financial results for the quarter and half-year. Consolidated revenue rose to Rs. 221.89 Cr from Rs. 157.49 Cr YoY, led by real estate and API segments. Consolidated net profit after tax and share of associate increased to Rs. 310.68 Cr...